These cases demonstrate the utility of GLP-1 agonists in treating dermatologic conditions that are refractory to other therapies and further highlight the potential of GLP-1 agonists in treating skin disease
Recalls & Warnings September 10, 2013 CoQ10 and Carnitine Supplement Company Warned For Manufacturing Violations On April 15, 2013, the FDA issued a warning letter to Irenda Corporation, following a facility inspection which found the company's products, including L-Carnitine, Acetyl L-Carnitine, and Co-Q 10 with L-Carnitine, to be adulterated because they were packed, or held under conditions that violate
If you have questions about weight management postpartum, reach out to your provider
Given that a significant portion of generic drugs and their active ingredients are sourced internationally, tariffs will also have the ability to strain supply chains and increase costs for consumers. In this article, we'll review the effect of tariffs on the medications commonly used by members of the Paloma Health patient community